June 15, 2015

Cosmederm Bioscience’s TriCalm OTC itch-relief solution was recognized in May by the journal Clinical, Cosmetic and Investigational Dermatology,, which published a study finding that Cosmederm’s solution was superior to diphenhydramine 2% and hydrocortisone 1%.

May 7, 2015

A journal study found that itch reliever TriCalm was superior in performance when compared with diphenhydramine 2% and hydrocortisone 1%.

September 15, 2014

Bayer HealthCare on Monday launched Aleve PM, the first over-the-counter nighttime product with a safe sleep aid plus the 12-hour pain-relieving strength of Aleve.

April 23, 2013

The Food and Drug Administration has approved a second product in BD's new line of injectable drugs, the company said Tuesday.

April 9, 2013

Cosmederm Bioscience announced that a study recently published in the journal Acta Dermato-Venereologica has established its TriCalm anti-itch product has greater anti-itch efficacy as compared with products containing hydrocortisone or diphenhydramine.

March 27, 2013

The Food and Drug Administration has approved a drug administered through a new line of injection devices made by BD, the company said Wednesday.

November 29, 2012

While the term homeopathy may remain as foreign to the American consumer as allopathy, more and more shoppers are placing those homeopathic products in their baskets. 

October 10, 2012

AccuDial Pharmaceutical recently launched four products as part of its Go-Green pediatric liquid cough-cold lineup that features dosing information on a rotating label, a larger 6-point font and a dosing cup that's shrink-wrapped to the top of the container.

August 20, 2012

UrgentRx will be adding an allergy relief product to its portfolio of on-the-go OTC solutions in October, the company recently announced.

June 18, 2012

Procter & Gamble on Monday officially announced the introduction of ZzzQuil, a sleep aid addition to its Vicks NyQuil and Vicks DayQuil brands.

March 28, 2011

The U.S. Pharmacopeial Convention last week announced that it is working with the Food and Drug Administration and the Consumer Healthcare Products Association to update quality standards for widely used medicines and ingredients. Updated test methodologies are crucial to help counter economically motivated adulteration — in which less expensive and potentially harmful ingredients are substituted for genuine medicines or their ingredients — and also to address the challenge of impurities that may go undetected with older, nonspecific assays and tests.

November 22, 2010

Johnson & Johnson is recalling millions of packages of OTC drugs for allergies and pain due to manufacturing problems ...